elimination from the bloodstream [3, 4] . Pluronics ® , which is constituted by poly(ethylene oxide) and poly(propylene oxide) blocks [5] , is currently a common studied system, although copolymers containing poly(L-amino acid) and polyester hydrophobic blocks are gaining interest [2] . Amphiphilic molecules of cyanoacrylate have also been widely studied as drug delivery systems. These compounds are now prepared mainly by radical copolymerization reactions in monophasic organic solvents like dimethyl formamide or butanone [6, 7] , or in two-phase solvents where the monomers dissolve each in one of the two phases [8] [9] [10] . Another method of preparation of cyanoacrylate amphiphilic copolymers is based on the condensation reaction of methoxy polyethylene glycol cyanoacetate and hexadecyl cyanoacetate with formaldehyde in the presence of an organic solvent like methylamine [11] . These methoxy polyethylene glycol cyanoacrylate-co-hexadecyl cyanoacrylate copolymers, abbreviated as poly(MePEGCA-co-HDCA), can be prepared with modulated hydrophobicity/hydro hilicity by adjusting the MePEGCA/HDCA monomer ratio. Some previous works focused on the preparation of nanoparticles from poly(MePEGCA-co-HDCA) with a hydrophilic/hydrophobic monomer ratio of 1:4 by nanoprecipitation and emulsion/solvent evaporation methods [11, 12] . Monomodal size distributions were obtained with characteristic mean particle sizes ranging between 98 and 199 nm and varying according to polymer concentration and the applied method. It was also demonstrated that nanoparticles have an adequate density of MePEG chains on their surface to provide enhanced stability in the blood compartment and ensure a long circulating characteristic [13, 14] . Nanoparticles of poly(alkyl cyanoacrylate) amphiphilic copolymers have recently been successfully used for other biomedical applications such as human brain endothelial cell imaging [15] and early Alzheimer's disease diagnosis and treatment [16] . Drug loaded nanoparticles of poly(MePEGCA-co-HDCA) have also recently been prepared using a new methodology based on solvent displacement in confined impinging jet mixers (CIJM) [17] . These devices allow continuous production, facilitate scaling-up and guarantee controllable operating parameters and conditions to improve final nano particle properties [18] . The solvent (e.g. acetone or tetrahydrofurane) and the anti-solvent streams (e.g. water)
are mixed under different flow conditions, defined by and labelled in terms of the anti-solvent/solvent flow rate ratio (R) and the flow rate of the anti-solvent stream (F W ). Besides their usefulness to get nanospheres constituted by the polymer alone, CIJM allow also the preparation of nanocapsules containing an oily core. Miglyol 812, a triglyceride of caprylic and capric fatty acids, seems appropriate to provide an oil core where water-insoluble drugs remain dissolved, resulting in high payload and a low release profile [19, 20] . The present work is devoted to the improvement of the physico-chemical characterization of poly (MePEGCA-co-HDCA), paying attention to its morphology and crystalline structure and also to its degradability. Furthermore, morphological features of poly(MePEGCA-co-HDCA) nanospheres and nanocapsules prepared using CIJM are described, and finally the drug loading and release from these nanoparticles are compared by using triclosan as an example of hydrophobic drug.
Experimental section 2.1. Materials
Methoxy poly(ethylene glycol) (MePEG) with a number average molecular weight of 2000 g/mol was purchased from Sigma-Aldrich (St. Louis, MO, USA). Poly(MePEGCA-co-HDCA) and poly(hexadecyl cyanoacrylate) (PHDCA) were synthesized as previously reported [11] being 3600 and 5100 g/mol, respectively, the number average molecular weights determined by gel permeation chromatography (GPC). Poly(MePEGCA-co-HDCA) was synthesized from a methoxypolyethylene glycol cyanoacetate to n-hexadecylcyanoacetate ratio of 1:4. Triclosan for release experiments was purchased from Sigma Aldrich. A microbial culture was prepared with reagents and labware from Scharlab S.L. (Barcelona, Spain). The bacterial strains were Escherichia coli CECT 101 and Micrococcus luteus CECT 245 from the Spanish Collection of Type Culture (CECT, Valencia, Spain).
Measurements
Molecular weights were estimated by GPC using a liquid chromatograph (Shimadzu, model LC-8A, Shimadzu Corp., Tokyo, Japan) equipped with an Empower computer program (Waters Corporation, Massachusetts, USA). A PL HFIP gel column (Agilent Technologies Inc., CA, USA) and a refractive index detector (Shimadzu RID-10A, Shimadzu Corp., Tokyo, Japan) were employed. The polymer was dissolved and eluted in tetrahydrofurane at a flow rate of 0.5 mL/min (injected volume 100 µL, sample concentration 1.5 mg/mL). The average molecular weights were calculated using polystyrene standards. 1 
Preparation of unloaded and triclosan
loaded nanospheres and nanocapsules of poly(MePEGCA-co-HDCA) Nanospheres and nanocapsules of poly(MePEGCAco-HDCA) containing triclosan were prepared by the solvent displacement method (or nanoprecipitation) [21] using a CIJM with two inlet jets of 1 mm, one outlet jet of 2 mm and a mixing chamber of about 5 mm. More geometrical details on this device can be found in previous work [18] . For the preparation of nanoparticles, 150 mg of poly(MePEGCAco-HDCA) was dissolved in 25 mL of warm acetone (i.e. polymer concentration of 6 mg/mL). To obtain triclosan loaded nanoparticles, 0.3% (w/v) of triclosan was added to the acetone solution. This solution was injected into the mixer by an infusion pump at a flow rate of 120 mL/min (KDS200, KD Scientific Inc., Holliston, MA, USA). Simultaneously, 25 mL of water was injected at the same rate through the second upstream inlet. R and F W processing parameters were consequently 1 and 120 mL/min, respectively. Particles, spontaneously formed in the mixer chamber, were evacuated by the outlet jet, and then quenched in 25 mL of water under magnetic stirring. Finally, the acetone was evaporated in Valente et al. -eXPRESS Polymer Letters Vol.7, No.1 (2013) [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] a rotating device (30 minutes at room temperature) to obtain an aqueous suspension of nanospheres. Nanocapsules were prepared by the same procedure after adding 200 #L of Miglyol 812 (i.e. oil concentration of 8 µL/mL) to the initial organic solution of the copolymer in order to form the inner oily cavity. Nanocapsules had an oil to polymer mass ratio of 1.26. Nanosphere and nanocapsule suspensions were extensively dialyzed (Spectra/Por ® 3500 MWCO dialysis membrane, Spectrum, Huston, TX, USA) at 25°C for 4 hours against a Sörensen solution supplemented with 10% (v/v) of ethanol in order to remove all unloaded triclosan. Aliquots of 200 #L of the sample suspension before and after dialysis underwent ultra-sound treatments and extracted with 1 mL of 70% ethanol to quantify triclosan by ultraviolet (UV) analysis (281 nm). Calibration curves were obtained by plotting the absorbance measured at 281 nm against triclosan concentration. Entrapment efficiency (EE) and drug loading (DL) were determined by Equations (1) and (2), respectively. Occurrence of degradation during dialysis was not considered for DL evaluation (i.e. Equation (2) was referred to the initial polymer mass).
(1) (2)
Degradation experiments
Degradation was performed using small polymer disks with a diameter of 1 cm and a thickness of 1 mm prepared by press molding of approximately 150 mg of the material. The degradation medium consisted of 15 mL of milliQ water and two different degradation temperatures (4 and 18°C) were considered. Tablets were removed from the degradation medium at scheduled times, and were then well dried and weighed to calculate the weight loss. Some samples were also analyzed by 1 H NMR to evaluate the chemical degradation of the polymer.
Release experiments
10 mL of the aqueous suspension containing triclosan loaded nanoparticles or nanocapsules (3 mg/mL) was confined in a dialysis bag which was introduced in a vessel equipped with magnetic stirring and containing 20 mL of the selected release medium (i.e. a mixture (3/7 v/v) of Sörensen medium (pH 7.4) and ethanol). Aliquots (1 mL) were drawn at predetermined intervals to determine the amount of released triclosan by UV spectroscopy. The volume of the release medium was kept constant by addition of 1 mL of fresh medium after removal of each aliquot. All drug release tests were carried out using five replicates to control the homogeneity of the release and average the results. The triclosan remaining in the samples was determined again by UV analysis. In this case, aliquots (200 #L) of the dialysis bag sample were sonicated and extracted with 1 mL of 70% ethanol to ensure complete dissolution of triclosan. The release kinetics can be calculated from experimental results by several theoretical models, typically first-order [22, 23] , Higuchi [24, 25] and their combination [26] . Thus, the Higuchi-equation (Equation (3)) and first-order (Equation (4)) models were used to describe the first (0-60%) and second (40-100%) parts of the release, respectively:
,$
where k h is the Higuchi release constant, k 1 is the first-order release constant, a takes into account the release in the first step, M t is the percentage of drug released at time t, and M 0 is the drug equilibrium percentage (considered as the maximum drug percentage).
Antibacterial activity
The in-vitro antibacterial activity of triclosan loaded nanoparticles and nanocapsules was evaluated using the Gram-positive Micrococcus luteus (M.luteus) and Gram-negative Escherichia coli (E.coli) microorganisms. Briefly, 7 mL of Luria-Bertani (LB) broth containing 10 5 CFU/mL was mixed with 1 mL of the nanosphere or nanocapsule aqueous suspension in sterile tubes. These were inverted 4-6 times to ensure mixing and incubated for 24 and 48 h in a shaking incubator at 100 rpm and a temperature of 37°C. Cultures of LB broth without and with bacteria were 
performed as negative and maximum bacterial growth controls, respectively. Culture of pure LB broth was the negative control, and pure LB broth with nanoparticles or nanocapsules was also tested as turbidity blank. Bacterial growth was determined by measuring turbidity at 600 nm by UV spectroscopy. The number of surviving bacteria was computed according to the relative growth rate (percentage), which was calculated from turbidity changes after 24 and 48 h of incubation. Activities were evaluated using six replicates for which the corresponding average value and standard deviation were determined. Two samples were considered statistically significantly different when ANOVA and " 2 -test gave p % 0.05. The antibacterial effect in a dose-response manner was also determined for triclosan-loaded nanocapsules by considering different dilutions of the sample and evaluating the relative growth, as noted above. The dose-response effect was analyzed by a logistic model using OriginPro v8 software (Origin Microcal Corp., Norhampton, MA, USA).
3. Results and discussion 3.1. Thermal characterization of poly(MePEGCA-co-HDCA) Poly(MePEGCA-co-HDCA) has a semicrystalline nature, as shown by the DSC scans in Figure 1a . Thus, the as-synthesized sample has a predominant peak at 53°C and a minor one close to 33-34°C, which should correspond to the melting of crystalline domains of PEG and hexadecyl (HD) alkyl groups, respectively. The sample easily crystallized from the melt, giving rise to a complex exothermic peak where the crystallization of the two indicated domains could not be well differentiated. It is inter- esting to note that the crystallinity of the as-synthesized sample, which came from evaporation of a dichloromethane solution, was slightly higher than that of the hot crystallized sample (i.e. the global melting enthalpy changed from 133 to 125 J/g). This increase was caused by the higher endothermic peak associated with the PEG domain (ca. 53°C) that could overcome the more deficient arrangement of the HD domain, which led to a very low melting peak at 33.4°C. This peak clearly increased after hot crystallization indicating an improved packing of HD chains. Some differences are also found in the melting peak associated with the PEG domain since a shoulder, which is indicative of a typical re-crystallization or lamellar thickening process, was observed for the as-synthesized sample whereas only a single peak was detected for the hot crystallized sample. The DSC heating run of a quenched sample does not reveal significant changes and demonstrates that the sample crystallized easily even at the high cooling rates given by the equipment. Note that the glass transition temperature could not be well observed due to the high crystallinity of the sample but it should be close to -63°C, as reported for PEG of low molecular weight [27] . Two points are worth highlighting from the thermal analysis: a) The sample undergoes a partial fusion at around 34°C, a temperature slightly lower than the human body temperature, at which the potential drug delivery systems should be applied; b) Despite the complexity of the sample, its crystallinity remains high at 37°C, which is the temperature at which samples are meant to be used. For the sake of completeness, Figures 1b and 1c show representative DSC scans performed with PHDCA and PEG homopolymers, respectively. These traces clearly confirm the previous assignation given for the melting peaks of poly(MePEGCAco-HDCA) and the similar crystallization temperature of both samples. Results also demonstrated that poly(MePEGCA-co-HDCA) has an intermediate melting enthalpy between those of the crystals constituted by the two types of lateral chains. The enthalpies associated with each peak (e.g. 21 and 104 J/g for the hot crystallized sample) fit reasonably well with the expected values (20 and 103 J/g) assuming a weight percentage of PEG close to 61%. Finally, the complexity of the crystallization exothermic peak of PEG, which extends over an interval of approximately 15°C, and the sharp appearance of the peak associated with the PHDCA homopolymer are worth noting. This also suggests a practically instantaneous primary crystallization that might result from a high nucleation density.
Spherulitic morphologies of poly(MePEGCA-co-HDCA)
Crystallization from the melt led to the formation of spherulites with a fibrillar/ringed texture corresponding to the crystallization of the PEG lateral chains, although domains constituted by HD units could also be envisaged. Figure 2a shows a typical crystallization performed at 4°C (i.e. at a low degree of supercooling) where well developed spherulites were observed, together with zones with a different texture (indicated by arrows in Figure 2a ) that seem to be constituted by smaller microcrystals. These zones melted when the sample was heated to the melting temperature associated with the PHDCA domains ( Figure 2b ) and re-crystallized, giving textures similar to those initially observed when the temperature was decreased to room temperature (Figure 2c ). Experiments clearly highlighted the complex crystallization process of samples constituted by blocks able to crystallize independently (i.e. those constituted by the PEG and HD lateral groups) and furthermore with a similar crystallization temperature. Phase separation and crystalline morphology studies of block copolymers are currently receiving much attention [28] [29] [30] [31] [32] , and even microstructures that can be formed from the melt, from solution and for both thin and bulk samples have been extensively reviewed [33, 34] . Ringed spherulites with an interspacing close to 9 µm could also be detected in the specimens (Figure 2d ) although at a lower ratio. A fibrillar spherulitic texture was observed when crystallization was performed at lower temperatures (e.g. -24°C), as shown in Figure 2e . The nucleation density obviously increased with decreasing the crystallization temperature; consequently, smaller spherulites were found at the end of the crystallization process. In this way, an increase from 20 to 600 nuclei/mm 2 was determined when the temperature decreased from 4 to -24°C. In all cases, a negative birefringence was characteristic of the PEG spherulites, whereas a more confusing sign was found for the domains constituted by the HD alkyl chains due to their smaller size. In fact, primary nucleation seemed to be much higher for these domains, giving rise to microcrystals. It should be pointed out that DSC data indicated that the hot crystallization of PHDCA proceeded rapidly, which was well justified by assuming a high primary nucleation. Optical micrographs revealed that the alkyl chain microcrystals had a flat appearance and usually appeared aggregated in such a way that the birefringence sign of the PEG spherulite was kept (see white and red arrows in Figure 2e ). In some cases, these microcrystals led to the formation of spherulite arms with a speckled appearance (white arrows). Phase separation was confirmed by electron diffraction since fibrillar textures and microcrystals gave rise to the typical hk0 pattern of PEG and a well differentiated pattern with six reflections at 0.415 nm, respectively. This pattern (Figure 3) suggests a pseudo-hexagonal packing of alkyl chains, which is consistent with the well known first-order transition undergone by long-chain paraffins at a few degrees below their melting point [35] . (Figure 4a ) of poly(MePEGCA-co-HDCA) revealed the presence of reflections characteristic of polyethylene glycol, as well as additional peaks which should be assigned to a crystalline structure associated with the packing of the hexadecyl lateral groups. The structure of polyethylene glycol is defined by a P2 1 /a space group and a unit cell with parameters a = 0.805 nm, b = 1.304 nm, c (fiber axis) = 1.948 nm and # = 125.4°t hat contains four 7/2 helices based on TTG sequences [36] (Figure 4b ). The corresponding Xray diffraction pattern (Figure 4c ) was characterized by strong peaks at 0.462 nm (120 reflection) and 0.386-0.277 nm (112, 032, 132 and 212 reflections) and weak peaks at 0.603 and 0.586 nm, which are indexed as the 021 and 110 reflections. All characteristic reflections of PEG, together with peaks at 2.988, 1.494 and 0.416 nm of remarkable intensity, can be well observed in the X-ray diffraction profile of poly(MePEGCA-co-HDCA). These peaks, which are also detected in the diffractogram of PHDCA, suggest the presence of a hexagonal unit cell with parameters a = 0.479 nm, b = 0.479 nm, c (fiber axis) = 2.988 nm. Note that the strong peak at 0.416 nm corresponds to the 100, 010 and 110 reflections, which were also observed in the electron diffraction patterns of HDCA spherulitic domains, and that are typical of a hexagonal packing of polymethylene segments. The higher spacing peaks can be indexed as the 001 and 002 reflections of a cell which c axis parameter corresponds to two lateral groups since the dimension of the alkyl side group becomes close to 1.5 nm (i.e. the 002 spacing) if an extended zig-zag conformation is assumed (Figure 5) . It must also be pointed out that a syndiotactic disposition of the hexadecyl lateral groups is preferred to avoid high steric hindrances between the polymethylene sequences of neighboring chain units (i.e. a value close to 0.25 nm should be expected for an isotactic configuration).
Hydrolitic degradation of
poly(MePEGCA-co-HDCA) Degradation of poly(MePEGCA-co-HDCA) in distilled water at temperatures of 18 and 4°C occurred over a maximum period of 8 h, followed by a slow process that extended over approximately 48 h. After that, the weight of the copolymer samples remained practically constant, at least over an exposure time of 300 h. The weight loss profiles at the two assayed temperatures were similar, although a slightly higher mass loss was detected at 18°C (Figure 6) . Thus, weight losses of 63 and 67% were determined at the end of the test performed at 4 and 18°C, respectively. Enhanced solubility at the higher temperature is the probable cause of the slight differences in the remaining weight. As already mentioned the copolymer was synthesized from a hydrophilic-to-hydrophobic monomer ratio of 1:4. However, this ratio should represent an 'average' value of the units incorporated to the polymer chain, and although the synthesis protocol is quite robust, it is likely that a distribution of hydrophilic-to-hydrophobic unit ratios exists in the final copolymer molecules. Thus, a significant weight loss should be expected from the presence of soluble fractions constituted by molecules with ratios of 1:2 or higher. The remaining part of the weight loss should be attributed to the hydrolysis of the ester groups of the hydrophilic lateral pegylated chains. Figures 7a and 7b compare the 1 H NMR spectra of the as-synthesized sample and that degraded up to a weight loss of 67%. The initial sample was characterized by an average molar ratio close to 1:4 between pegylated and hexadecyl (HD) lateral chains, as can be deduced from the areas of the signals at 3.37 and 0.86 ppm assigned to the methyl groups belonging to the two ester moieties [11] . Methylene groups of the main chain and the lateral hexadecyl and PEG groups also appeared well differentiated at 2.37, 1.25 and 3.64 ppm, respectively (Figure 7a) . Spectra of samples exposed to water clearly show how the PEG signals at 3.64 and 3.37 ppm practically disappeared while HD signals at 1.25 and 0.86 ppm remained with a remarkable intensity. In fact the hydrophilic-to-hydrophobic unit ratio decreases up to 1:110. Thus, the degradation process could be justified by an ester group cleavage involving mainly the pegylated chains. According to the composition determined from NMR spectra, the MePEG lateral groups represented 55 wt% of the copolymer, which was slightly lower than the experimental weight loss. Thus, a percentage of the initial sample (i.e. chains with a high hydrophilic content) should be dissolved during exposure to the aqueous medium. In order to estimate this fraction, the as-synthesized sample was extracted with water in a time period during which degradation was practically negligible (i.e. less than 5% for 30 min of exposure). The extracted fraction corresponded to 10 wt% of the sample and its NMR spectrum (Figure 7c ) indicated a 1:1.4 ratio between MePEG and HD lateral chains that was in agreement with the ratio expected for soluble molecules. The preferential hydrolysis of pegylated chains was also corroborated by the 1 H NMR spectra (not shown) of the residue extracted from the hydrolytic degradation medium after 72 h of exposure, which indicated a PEG/HD ratio higher than 15:1. Furthermore, lamellar crystals with the characteristic morphology of polyethylene glycol lamellae [37, 38] were recovered after evaporation of the degradation medium. Specifically, Figure 6b shows typical square lamellae of PEG and the corresponding electron diffraction pattern with intense 120 reflections at 0.462 nm. In conclusion, 1 H NMR spectra pointed out that the sample weight loss occurred through ester bond cleavage of the hydrophilic pegylated chains and by solubilisation of a small fraction corresponding to the more hydrophilic copolymer fraction. It is interesting to note that the ester bond of the hydrophobic moiety was not highly susceptible to hydrolysis probably due to poor exposure to the degradation medium. These results are in full agreement with preliminary studies on fetal calf serum which indicate that the hexadecyl homopolymer did not degrade during the first 3 h of incubation [12] . Finally, it is also interesting to note that degradation of pegylated chains can lead to the formation of anionic carboxylate groups, which still provide a hydrophilic character to the polymer. 
Morphology of nanospheres and
nanocapsules Particle size and size distribution are the most important characteristics of nanoparticle systems since they influence their biological fate, toxicity, targeting ability and even drug loading, drug release and stability. Many studies have demonstrated that nanoparticles of sub-micron size have a number of advantages over micro-particles, for example as a drug delivery system because of their small size and relative mobility. These properties can improve intracellular uptake and increase availability to a wider range of biological targets [39] . DLS analysis revealed a size difference between the triclosan loaded nanoparticles and nanocapsules. Thus, unimodal size distributions with mean diameters of 160±60 nm (Figure 8a ) and 230±60 nm (Figure 8b) , respectively, were found. Scanning electron micrographs (Figure 8c) showed that nanoparticles were mostly spherical and had a rather variable diameter, in agreement with DLS results. Particles were generally found isolated although some aggregates could also be observed.
TEM micrographs taken at a higher magnification showed that particles, directly deposited on the carbon grid, were constituted by a porous dense polymer matrix (Figure 9a) . Furthermore, these nanoparticles often appeared slightly deformed, their rounded appearance being lost, as clearly seen in the negative stained samples (Figure 9b ). Nanoparticles were also shadowed with Pt/C to determine their thickness and confirm their spherical morphology. Thus, the maximum and minimum shadows in the micrograph in Figure 10 correspond to thicknesses of 230 and 115 nm, which are again in agreement with the particle size distribution determined by DLS measurements. Medium magnification TEM images of nanocapsules (Figures 11a and 11c) showed their morphology and confirmed the underlying size distribution. This distribution extended over the 110-290 nm range, which covers smaller diameters than those deduced from DLS analysis. However, the predominant nanocapsule size (ca. 200 nm) was close to the average value previously determined. Direct and negative stained images showed that isolated nanocapsules were practically spherical but easily deformed when they were aggregated. Thus, the adjacent nanocapsule membranes became parallel and planar (see arrows in the negative stained sample of Figure 11c) , showing that the spherical shape is actually not rigid. Both the liquid content and the reduced stiffness of the polymer membrane should be taken into account. The inset of Figure 11c contains the two wall membranes with a probable thickness of approximately 5 nm, since it can be considered that the negativation salt had not penetrated in the nanocapsules or between adjacent membranes. Specimens obtained by direct deposition are sensitive to the large intensity of the electron beam. For this reason, some nanocapsules broke down during observation and released their liquid content. Note in Figure 11b some dense particles corresponding to the polymer membrane on the edges of the oil released by the breaking down of the nanocapsule. Figures 12a and 12b reproduce bright field images of nanocapsules directly deposited onto the copper grid where the membranes can be clearly discerned in the projection contrast and a wall thickness close to 5 nm measured. Most nanocapsules were surrounded by a somewhat bright halo, which could be attributable to the oil released by the breaking down of the nanocapsule during observation. The polymer matrix should be amorphous, but it is not discarded that side groups could crystallize. Moreover, some degraded pegylated chains and even some aggregated polymer molecules could be encapsulated, accounting for the dark zones found in nanocapsules (Figures 12a-12c) . Pt/C shadowed samples (Figure 10d ) revealed that nanocapsules usually collapse, giving rise to almost flat, rounded morphologies (note the shadow in Figure 12d , which suggests a small thickness). Flat morphologies were again a consequence of the oil release and the spongy structure of the polymer filled with liquid. It should be pointed out that shadowed samples allowed the detection of regular crystals inside the nanocapsule, as deduced from the surface details in Figure 12d . Specifically, aggregates of square crystals similar to those characteristic of PEG could be clearly envisaged. 
Release of triclosan from nanospheres and nanocapsules
Encapsulation efficiency (EE) was high and similar for both nanospheres and nanocapsules since values of 92 and 91% were respectively determined. It is clear that the polymer and the preparation method were effective in encapsulating high doses of triclosan. Drug loading (DL) was consequently relatively high and again similar for both systems (43 and 44% for nanospheres and nanocapsules, respectively). The amount of drug entrapped determines the performance of the drug delivery system as it influences the rate and extent of drug release from the system. Both DL and EE depend on physicochemical properties and the interactions between the drug, the carrier matrix, the encapsulated oil and the surrounding medium.
Triclosan release has been studied in Sörensen medium containing 70 volume percentage of ethanol in order to increase the hydrophobicity of the medium and avoid reaching an equilibrium condition. The studied mixture had previously been found to give similar triclosan release results in more expensive serum-based media [40] . Release of triclosan from nanoparticles and nanocapsules is clearly different, as compared in Figure 13a . Thus, the profile of nanospheres showed an initial Burst effect up to a percentage close to 35% which was mainly caused by the drug deposited on or close to the particle surface, followed by a slower, gradual release indicative of an effective hydrophobic interaction between the drug and the hydrophobic hexadecyl groups. On the contrary, the Burst effect was not significant when using nano - capsules and a sustained release over a period greater than 120 h was observed. The polymer was able to confine the oil effectively despite possible degradation of pegylated chains, and triclosan remained preferentially in the hydrophobic oil core, reducing the Burst effect and release rate. Both nanospheres and nanocapsules showed a maximum drug release close to 80%. It seems that some triclosan was entrapped in the two cases and could not diffuse effectively through the polymer matrix or polymer membrane, respectively, at an appreciable rate.
Release of triclosan from nanospheres was interpreted with the first-order equation only, since the 40% initial release could be ascribed to a Burst effect, as above indicated. The kinetic constant for this step was 0.073 h -1 . In contrast, a combined model was required to interpret the release from nanocapsules. In this case, kinetic constants close to 0.145 h -0.5 and 0.024 h -1 were derived by fitting the first (Higuchi model) and second (first-order model) steps of the release. It is interesting to highlight the threefold decrease of the kinetic constant associated with the last release step, when using nanocapsules instead of nanospheres (i.e. 0.024 h -1 versus 0.073 h -1 ). Despite the expected low diffusion rate of triclosan in the polymer matrix, the result seems logical as there is a greater affinity between triclosan and glycerol than between the drug and the polymer matrix, resulting in an enhanced release from nanospheres. It must be pointed out that the assumption of the late-time Equation (4) for both NS and NC dosage forms implies that the amount of drug released at each time is proportional to the residual drug inside these forms. TEM micrographs were taken at the end of the release experiments (120 h) to find evidence of degradation. Nanospheres appeared clearly isolated and kept their rounded morphology and even their diameter size range (Figure 13b) . Hence, no morphological changes were reported after exposure to the release medium. More interesting were the high magnification images of nanocapsules (e.g. Figure 13c) where two points merit attention: a) The membrane wall appeared well preserved and had even swelled slightly, as deduced from the increase of the wall thickness (a value close to 10 nm was measured). Note also that in this case the wall thickness clearly decreased upon close contact of nanocapsules. In addition, the detected degradation of pegylated chains did not affect the consistency of the nanocapsule membrane. As indicated before, new anionic carboxylated groups should have formed by hydrolysis, providing again a hydrophilic outer surface that stabilized the membrane in the water containing release medium; b) Drops can be clearly envisaged in the nanocapsule cores. Molecules of the release media (ethanol and water) were likely to have crossed the membrane, causing a swelling effect and microphase separation.
Antibacterial effect of the nanospheres and nanocapsules loaded with triclosan
The antibacterial activity of triclosan loaded nanocapsules and nanospheres was tested by direct contact with microorganisms. Figure 14a shows the relative growth of E.coli (Gram-negative bacterium) and M.luteus (Gram-positive bacterium) after 24 and 48 hours of culture in the presence of these nanospheres and nanocapsules. E.coli was especially sensitive to the antibacterial action of triclosan. Thus, the inhibition of bacterial growth after 24 h of culture was about 80% for both nanospheres and nanocapsules. It may be inferred from the above results that the antibacterial effect was due to the release of approximately 50 and 80% of loaded triclosan in the nanocapsules and nanospheres, respectively (Figure 13a ). The triclosan release ensured that bacterial growth inhibition was maintained around 80% after 48 h of culture. M.luteus showed greater resistance to triclosan as the inhibition of bacterial growth was only about 10 and 20% after 24 h of culture for nanocapsules and nanospheres, respectively (Figure 14a ). Notice that, as expected, inhibition was greater for the former because of their higher triclosan release rate. After 48 h of culture, a statistically significant increase in the inhibition of bacterial growth was reported, with values of 20 and 40% for nanocapsules and nanospheres, respectively. Note that the relative inhibition doubled with increasing the drug release period. Thus, results clearly indicate that progressive release of triclosan from both nanospheres and nanocapsules increased the antibacterial effect. It is clear that M.luteus growth is sensitive to the amount of triclosan released, as is typical in the antimicrobial control of Gram-positive bacteria. Two approaches can be taken to solve this sensitivity problem: a) Preparation of nanospheres or nanocapsules with a higher drug load, which is not desirable since a change of the mass ratio between polymer and drug is required; b) Exposure of bacteria to a medium containing more nanospheres or nanocapsules. Figure 14b shows the antimicrobial effect of triclosan loaded nanospheres and nanocapsules in relation to the number of dosage forms, which was easily managed by controlling the dilution of the NS/NC suspension with the broth medium. A direct linear relationship between the antibacterial effect and the number of triclosan loaded nanospheres and nanocapsules was logically found. Specifically, correlation coefficients, r, of 0.987 and 0.999 were obtained for the NS and NC relationships, respectively. 
Conclusions
The amphiphilic copolymer derived from methylated polyethylene glycol and hexadecyl cyanoacetate esters with a hydrophilic/hydrophobic monomer ratio close to 1:4 was semicrystalline and able to develop large spherulites by crystallization from the melt state. Morphological observations, calorimetric data and X-ray and electron diffraction patterns pointed out the existence of two crystalline domains. These could be associated with polyethylene glycol and a hexagonal phase corresponding to the packing of the long alkyl lateral groups. The copolymer hydrolyzed in water by cleavage of ester bonds involving the hydrophilic polyethylene glycol groups, whereas ester bonds involving the hydrophobic hexadecyl groups appeared well preserved.
The solvent displacement method coupled with the use of CIJM was highly effective in preparing triclosan loaded nanospheres and nanocapsules. Encapsulation efficiency was always close to 90% and an approximate 40% drug load was easily obtained.
Morphological observations and DLS measurements indicated that NS and NC samples had size distribution centered at around 160 and 230 nm, respectively. Nanocapsules were characterized by a polymer membrane with a thickness close to 5 nm, a spongy structure that was easily deformed and the presence of crystallizable PEG chains in the oil core. Nanocapsules kept their morphology during exposure to the release medium (minimum 72 h), although a slight swelling of the membrane wall was observed. Solvent molecules were able to cross the membrane, which was unaffected by the increase of the hydrodynamic pressure. Nanospheres and nanocapsules exhibited a well differentiated triclosan release; specifically, the latter allowed a controlled, sustained release without Burst effect. The antimicrobial effect was also significantly different, especially when Gram-positive bacteria were assayed. A higher relative growth was always found for nanocapsules due to their lower triclosan release rate.
